These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Do we know the benefits of a taurolidine lock in adult home parenteral nutrition patients with a low infection rate? Olthof ED, Broekman MM, Wanten GJ. JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385. PubMed ID: 25883235 [No Abstract] [Full Text] [Related]
27. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Betjes MG, van Agteren M. Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498 [Abstract] [Full Text] [Related]
28. Risk factors for the development of catheter-related bloodstream infections in patients receiving home parenteral nutrition. Buchman AL, Opilla M, Kwasny M, Diamantidis TG, Okamoto R. JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):744-9. PubMed ID: 23744839 [Abstract] [Full Text] [Related]
29. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients. Gudiol C, Arnan M, Aguilar-Guisado M, Royo-Cebrecos C, Sánchez-Ortega I, Montero I, Martín-Gandul C, Laporte-Amargós J, Albasanz-Puig A, Nicolae S, Perayre M, Berbel D, Tebe C, Riera J, Sureda A, Cisneros JM, Carratalà J. Antimicrob Agents Chemother; 2020 Jan 27; 64(2):. PubMed ID: 31712211 [Abstract] [Full Text] [Related]
30. Epidemiology of Infectious and Noninfectious Catheter Complications in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Meta-Analysis. Reitzel RA, Rosenblatt J, Chaftari AM, Raad II. JPEN J Parenter Enteral Nutr; 2019 Sep 27; 43(7):832-851. PubMed ID: 31172542 [Abstract] [Full Text] [Related]
31. Taurolidine-related adverse events in patients on home parenteral nutrition frequently indicate catheter-related problems. Korzilius JW, Gillis VELM, Wouters Y, Wanten GJA. Clin Nutr; 2022 Oct 27; 41(10):2178-2184. PubMed ID: 36067590 [Abstract] [Full Text] [Related]
32. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. JPEN J Parenter Enteral Nutr; 1998 Oct 27; 22(4):242-4. PubMed ID: 9661127 [Abstract] [Full Text] [Related]
34. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial. Bueloni TNV, Marchi D, Caetano C, de Souza Cavalcante R, Mendes Amaral ML, Ponce D. Int J Infect Dis; 2019 Aug 27; 85():16-21. PubMed ID: 31102823 [Abstract] [Full Text] [Related]
35. Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition. Daoud DC, Wanten G, Joly F. Nutrients; 2020 Feb 10; 12(2):. PubMed ID: 32050544 [Abstract] [Full Text] [Related]
37. Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition. Vernon-Roberts A, Lopez RN, Frampton CM, Day AS. JPEN J Parenter Enteral Nutr; 2022 Sep 10; 46(7):1535-1552. PubMed ID: 35233792 [Abstract] [Full Text] [Related]
38. The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis. van den Bosch CH, Jeremiasse B, van der Bruggen JT, Frakking FNJ, Loeffen YGT, van de Ven CP, van der Steeg AFW, Fiocco MF, van de Wetering MD, Wijnen MHWA. J Hosp Infect; 2022 May 10; 123():143-155. PubMed ID: 34767871 [Abstract] [Full Text] [Related]